VB15010

· Zhejiang Yangli Pharmaceutical Technology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VB15010, covering 2025-02-11 to 2025-02-11. Get the full timeline:

Most recent: Clinical Trial Update: Phase I/II Clinical Study to Evaluate VB15010 Tablets in Patients With Advanced Solid Tumors [Phase 1, Phase 2]